“…Lee and coworkers reported the synthesis and characterization of new iridium complexes of (pq) 2 Ir(acac) and (pq) 2 Ir(tmd) (pq = 2-phenylquinoline anion, acac = acetylacetonate anion, and tmd = 2,2′,6,6′-tetramethylhepta-3,5-dione anion) with much higher ECL efficiencies at 589 and 593 nm compared to that of Ru(bpy) 3 2+ [16]. Subsequently, a large number of novel iridium(III) complexes with various ligands have been prepared for ECL studies [17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32]. In particular, heteroleptic iridium(III) complexes such as Ir(dfppy) 2 (bpy) [27] and Ir(dfppy) 2 (PyBiz) [32] (dfppy = 2-(2,4-difluorophenyl) pyridine, PyBiz = 2-(2-pyridyl)benzimidazolato-N,N′) as the primary cyclometalating ligand have shown the highly enhanced ECL response compared to that of Ru(bpy) 3 2+ .…”